Sellas Life Sciences Group, Inc. · NASDAQ:SLS
BlackRock, Inc. reported a 5.40% stake in Sellas Life Sciences Group, Inc. (Schedule 13G)
Event Sep 30, 2025 · Filed Oct 17, 2025
BlackRock, Inc. reported a 5.40% stake in Sellas Life Sciences Group, Inc., 5,686,886 shares, as a passive investor on Sep 30, 2025. Filed Oct 17, 2025 (Schedule 13G).
- Stake
- 5.40%
- Shares
- 5,686,886
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.40% | 5,686,886 |
Source
Related
- Sellas Life Sciences Group, Inc.
- BlackRock, Inc.
- Sellas Life Sciences Group, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Apr 24, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Stergiou Angelos M. · Jun 18, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13G/A · Anson Funds Management LP · Feb 17, 2026